Published in Crit Care Med on June 01, 2003
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*. Crit Care Med (2014) 1.55
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care (2008) 1.32
Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care (2004) 1.30
Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care (2011) 1.17
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Proven infection-related sepsis induces a differential stress response early after ICU admission. Crit Care (2010) 1.03
Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care (2008) 1.02
Pharmacologic agents for acute hemodynamic instability: Recent advances in the management of perioperative shock- A systematic review. Ann Card Anaesth (2015) 1.01
Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol (2011) 1.00
Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study. Crit Care (2010) 1.00
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care (2015) 0.93
Hormonal responses upon return of spontaneous circulation after cardiac arrest: a retrospective cohort study. Crit Care (2011) 0.90
Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract (2016) 0.89
Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol (2009) 0.89
Hemodynamic optimization of sepsis-induced tissue hypoperfusion. Crit Care (2006) 0.88
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One (2015) 0.88
Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth (2010) 0.84
Dear vasopressin, where is your place in septic shock? Crit Care (2004) 0.83
Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg (2011) 0.82
Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study. BMC Pharmacol Toxicol (2016) 0.82
The cardioprotective effect of hypertonic saline is associated with inhibitory effect on macrophage migration inhibitory factor in sepsis. Biomed Res Int (2013) 0.80
Vasopressin: Its current role in anesthetic practice. Indian J Crit Care Med (2011) 0.80
Thirst perception and osmoregulation of vasopressin secretion are altered during recovery from septic shock. PLoS One (2013) 0.80
Hyponatremia is a specific marker of perforation in sigmoid diverticulitis or appendicitis in patients older than 50 years. Gastroenterol Res Pract (2013) 0.79
Hepatosplanchnic circulation in cirrhosis and sepsis. World J Gastroenterol (2015) 0.78
Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa. Vasc Health Risk Manag (2006) 0.77
Septic encephalopathy: when cytokines interact with acetylcholine in the brain. Mil Med Res (2014) 0.77
Multiple alpha1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine. Am J Physiol Regul Integr Comp Physiol (2010) 0.76
Conventional, molecular methods and biomarkers molecules in detection of septicemia. Adv Biomed Res (2015) 0.76
Characterization of Brain-Heart Interactions in a Rodent Model of Sepsis. Mol Neurobiol (2016) 0.76
Sepsis in pregnancy and early goal-directed therapy. Obstet Med (2009) 0.75
Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article. Hepat Mon (2015) 0.75
Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort. World J Hepatol (2017) 0.75
Postreperfusion syndrome during liver transplantation. Korean J Anesthesiol (2015) 0.75
Does vasopressin improve the mortality of septic shock patients treated with high-dose NA. Indian J Crit Care Med (2016) 0.75
Normality. Crit Care Med (2004) 0.75
Nephroprotective strategies in septic shock: the VANISH trial. J Thorac Dis (2016) 0.75
Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin. Inflammation (2016) 0.75
Role of vasopressin in current anesthetic practice. Korean J Anesthesiol (2017) 0.75
[Use of vasopressors and inotropics in cardiogenic shock]. Herz (2017) 0.75
Could hyponatremia be a marker of anastomotic leakage after colorectal surgery? A single center analysis of 1,106 patients over 5 years. Langenbecks Arch Surg (2014) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol (2005) 5.99
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol (2004) 3.64
Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis (2003) 2.56
Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol (2006) 2.50
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33
ICU physicians should abandon the use of etomidate! Intensive Care Med (2005) 2.32
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
Medical and socio-professional impact of insomnia. Sleep (2002) 2.05
Decompression sickness in urban divers in France. Int Marit Health (2012) 1.98
Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87
Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med (2002) 1.86
Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med (2010) 1.77
Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol (2002) 1.75
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
Sepsis-associated delirium. Intensive Care Med (2007) 1.72
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66
Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res (2006) 1.66
Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med (2005) 1.63
A balanced view of balanced solutions. Crit Care (2010) 1.61
RhBG and RhCG, the putative ammonia transporters, are expressed in the same cells in the distal nephron. J Am Soc Nephrol (2003) 1.61
Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis (2011) 1.60
Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59
Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol (2011) 1.57
Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med (2008) 1.54
The neuropathology of septic shock. Brain Pathol (2004) 1.53
Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock. Crit Care Med (2010) 1.53
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
StO₂ guided early resuscitation in subjects with severe sepsis or septic shock: a pilot randomised trial. J Clin Monit Comput (2013) 1.51
Expression of RhCG, a new putative NH(3)/NH(4)(+) transporter, along the rat nephron. J Am Soc Nephrol (2002) 1.50
The highs and lows of intensive insulin therapy. Am J Respir Crit Care Med (2006) 1.47
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature (2007) 1.46
Treatment of osteoradionecrosis of the jaw: the case against the use of hyperbaric oxygen. J Oral Maxillofac Surg (2010) 1.45
Masseter tissue oxygen saturation predicts normal central venous oxygen saturation during early goal-directed therapy and predicts mortality in patients with severe sepsis. Crit Care Med (2012) 1.45
The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology (2011) 1.44
Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice. Shock (2015) 1.43
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol (2006) 1.32
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
The Cl-/HCO3- exchanger pendrin in the rat kidney is regulated in response to chronic alterations in chloride balance. Am J Physiol Renal Physiol (2004) 1.31
Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol (2006) 1.29
Long-term outcome of iatrogenic gas embolism. Intensive Care Med (2010) 1.28
Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab (2003) 1.28
Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol (2006) 1.28
Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 1.28
Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol Dial Transplant (2008) 1.27
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2012) 1.25
Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension. Crit Care Med (2013) 1.24
Genetic ablation of Rhbg in the mouse does not impair renal ammonium excretion. Am J Physiol Renal Physiol (2005) 1.24
Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med (2011) 1.22
Glucocorticoids for ARDS: Just Do It! Chest (2007) 1.21
Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care (2009) 1.18
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med (2014) 1.17
Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord (2011) 1.16
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci U S A (2004) 1.16
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15
From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat (2011) 1.14
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Clinical review: corticotherapy in sepsis. Crit Care (2003) 1.11
Angiotensin II inhibits NaCl absorption in the rat medullary thick ascending limb. Am J Physiol Renal Physiol (2004) 1.10
Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med (2002) 1.08
Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care (2007) 1.08
Automatic air-leak compensation in neuromuscular patients: a feasibility study. Respir Med (2008) 1.07
Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med (2006) 1.07
Understanding brain dysfunction in sepsis. Ann Intensive Care (2013) 1.06
Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis (2009) 1.05
Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev (2010) 1.05
The encephalopathy in sepsis. Crit Care Clin (2008) 1.03
Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis. Intensive Care Med (2007) 1.02
Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J Clin Endocrinol Metab (2012) 1.02
NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B. J Biol Chem (2007) 1.02
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab (2011) 1.01
Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin (2011) 1.01
Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab (2006) 1.01
Regulation of the Cl-/HCO3- exchanger AE2 in rat thick ascending limb of Henle's loop in response to changes in acid-base and sodium balance. J Am Soc Nephrol (2004) 1.00
Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase. Kidney Int (2003) 1.00
Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med (2011) 0.99
Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med (2002) 0.99
Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology (2008) 0.98
Corticosteroid insufficiency in acutely ill patients. N Engl J Med (2003) 0.98
Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease. Neuromuscul Disord (2011) 0.96